PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and Approximately 18% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
Kahn Swick & Foti, LLC is reminding investors with substantial losses in PROCEPT BioRobotics (NASDAQ: PRCT) that they have until September 22, 2026 to file lead plaintiff applications in a pending securities class action in the U.S. District Court for the Northern District of California. The suit alleges Procept and certain executives failed to disclose that U.S. handpiece sales materially exceeded procedure volumes every quarter since Q1 2023, building cumulative excess field inventory of more than 10,000 units.
Key figures
- Class period
- February 28, 2024 to February 25, 2026
- Two day decline
- more than 18%
- Handpiece units q3 us
- 13225
- Handpiece units q4 us
- 9400
- Lead plaintiff deadline
- September 22, 2026
- Sequential unit decline
- nearly 30%
- Stock price feb 25 2026
- 27.84
- Stock price feb 27 2026
- 22.69
- Excess field inventory units
- more than 10,000
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.